Shingles vaccine prevents painful disease in older adults

October 17, 2012 by Sharyn Alden, Health Behavior News Service

Older adults who get the shingles vaccine have a nearly 50 percent reduced risk of developing the often debilitating disease, finds a new evidence review from The Cochrane Library.

, which originates from the same virus as the childhood disease , can severely impact quality of life for weeks or months.

Lead study author, Anna Gagliardi, Ph.D., professor of geriatrics and gerontology at Federal University in Sao Paulo, Brazil, explained, "The herpes zoster disease is an extremely painful condition that impacts the quality of patients' lives. People over 60 are particularly susceptible to developing the disease, but fortunately nowadays we have a for it." 

The shingles virus remains dormant in the nervous system of anyone who had chickenpox.  Later in life, when the immune system is more compromised, the virus may reappear in the form of shingles, a painful inflammation of

The vaccine is more effective for those 60 to 69 years old compared with people 70 and older since younger adults typically have a stronger immune system.  However, those in their 60s may experience more frequent side effects from the vaccine.

Gagilardi noted, "Adults over 70 have less immunity reaction from the vaccine, but the vaccine works. In general, the vaccine is well tolerated and it produces few systemic adverse reactions and only a mild or moderate adverse reaction at the site of the vaccination."

Researchers analyzed the effectiveness of the zoster vaccine from eight that included 52,259 people in several European countries and the U.S. The principal study, the Shingles Prevention Study, followed 38,546 participants for at least 3 years and one month after being vaccinated.

Jonathan S. Anderson, M.D., internist with the Dean Health System in Madison, Wisconsin, said, "The meta-analysis confirms what we knew before and what we see in practice: that the zoster vaccine reduces the risk of developing shingles over subsequent years.  Over the three years the study looked at the effects of the vaccine, the risk was cut in half.  Fifty people would need to receive the vaccine for one person to benefit by not getting shingles. This is reasonable given that shingles is not only very painful, it can develop into a chronically painful condition which is often difficult to treat."

Anderson added, "While the results of the study weren't surprising it may provide some impetus to vaccinate people sooner when they are still in their 60s instead of waiting and continuing to discuss it with patients over time."

Explore further: Shingles vaccine is safe, according to new study

More information: Gagliardi AMZ, Gomes Silva BN, TorloniMR, Soares BGO. Vaccines for preventing herpes zoster in older adults. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD008858. DOI: 10.1002/14651858.CD008858.pub2

Related Stories

Shingles vaccine is safe, according to new study

April 23, 2012
The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine.

Study challenges concerns on effectiveness of administering pneumococcal, shingles vaccines together

May 12, 2011
Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente ...

Short-term risk of shingles recurrence low

June 5, 2012
People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles, according to a Kaiser Permanente Southern California study published online in the Journal ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.